Evolve Private Wealth LLC Buys Shares of 51,089 BlackRock Capital Allocation Term Trust $BCAT

Evolve Private Wealth LLC acquired a new position in BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 51,089 shares of the company’s stock, valued at approximately $814,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Keebeck Wealth Management purchased a new stake in BlackRock Capital Allocation Term Trust during the second quarter worth $5,607,000. OneAscent Family Office LLC purchased a new position in shares of BlackRock Capital Allocation Term Trust in the 2nd quarter valued at $498,000. BlackRock Inc. purchased a new position in shares of BlackRock Capital Allocation Term Trust in the 2nd quarter valued at $152,000. Joseph P. Lucia & Associates LLC bought a new position in shares of BlackRock Capital Allocation Term Trust in the 2nd quarter worth $534,000. Finally, Global Retirement Partners LLC bought a new position in shares of BlackRock Capital Allocation Term Trust in the 2nd quarter worth $115,000. 36.12% of the stock is currently owned by institutional investors.

BlackRock Capital Allocation Term Trust Stock Performance

Shares of NYSE BCAT opened at $15.89 on Monday. BlackRock Capital Allocation Term Trust has a 1-year low of $13.73 and a 1-year high of $16.20. The business has a fifty day moving average price of $15.79 and a 200 day moving average price of $15.31.

BlackRock Capital Allocation Term Trust Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Tuesday, September 15th will be issued a $0.2542 dividend. The ex-dividend date is Tuesday, September 15th. This represents a c) dividend on an annualized basis and a yield of 19.2%.

BlackRock Capital Allocation Term Trust Company Profile

(Free Report)

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.

See Also

Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report).

Institutional Ownership by Quarter for BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.